nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.03.2020 | editorial

Evidence-based follow-up

verfasst von: Ewald Wöll, MD

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Although follow-up after primary treatment of cancer patients is our daily business, very few evidence-based strategies on the best modalities and time lines have been published so far. …

Vorheriger Artikel CAR(-T)s are on the road

Nächster Artikel End-of-life therapy: palliative care instead of palliative scare

Spanberger T. Evidence-based follow-up in patients with Hodgkin’s lymphoma and aggressive B-cell non-Hodgkin’s lymphoma. memo. 2020. https://doi.org/10.1007/s12254-020-00570-8.CrossRef

Stierer M. Evidence-based follow-up for breast cancer. memo. 2020. https://doi.org/10.1007/s12254-019-00531-w.CrossRef

Maglione M, Perathoner A. Evidence-based follow-up in colorectal cancer—quo vadis? memo. 2020. https://doi.org/10.1007/s12254-019-00553-4.CrossRef

Watzka S. Evidence-based follow-up in non-small-cell lung cancer. memo. 2020. https://doi.org/10.1007/s12254-019-00566-z.CrossRef

Ng C, Pircher A, Augustin F, Kocher F. Evidence-based follow-up in lung cancer?Focusing on the risk group of recently operated patients. memo. 2020. https://doi.org/10.1007/s12254-020-00575-3.CrossRef

Mayrhofer K, Niedersüß-Beke D. Evidence-based follow-up in renal cell carcinoma. memo. 2020. https://doi.org/10.1007/s12254-019-00540-9.CrossRef

Titel: Evidence-based follow-up
verfasst von: Ewald Wöll, MD
Publikationsdatum: 01.03.2020
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 1/2020
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-019-00568-x

Springer Medizin Österreich

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

End-of-life therapy: palliative care instead of palliative scare

Incidental thyroid papillary microcarcinoma on 1777 surgically treated patients for benign thyroid disease

Role of CAR-T cell therapy in B-cell acute lymphoblastic leukemia

Complete remission of disseminated Langerhans cell sarcoma after stem cell transplantation

CAR(-T)s are on the road

Importance of avoiding late cancer-directed therapy in terminally ill cancer patients